- Home
- MFP vs GHRS Comparison
MFP vs GHRS Comparison
Compare MFP & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$46.39
HOLD
Current Price
$28.13
Company Overview
Basic Information| Metric | MFP | GHRS |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MFP | GHRS |
|---|---|---|
| Price | $46.39 | $28.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $41.38 |
| AVG Volume (30 Days) | ★ 734.2K | 304.4K |
| Earning Date | N/A | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.00 | $11.83 |
| 52 Week High | $52.58 | $31.44 |
Technical Indicators
Market Signals| Indicator | MFP | GHRS |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 48.76 |
| Support Level | $42.85 | $28.05 |
| Resistance Level | N/A | $28.96 |
| Average True Range (ATR) | 2.85 | 1.25 |
| MACD | 0.30 | -0.24 |
| Stochastic Oscillator | 71.08 | 29.61 |
Price Performance
Historical Comparison MFP
GHRS
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.